MedTrace Logo

Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance

NCT02502344 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2016-07-21

No results posted yet for this study

Summary

This research would take medical interventions in subjects of insulin resistance without abnormal glucose tolerance, to see if there were different prevalence of abnormal glucose tolerance in different groups.

Conditions

Interventions

BEHAVIORAL

healthy lifestyle

food control and intensive exercise to lose weight

DRUG

Metformin

use metformin to reduce insulin resistance

Sponsors & Collaborators

  • Beijing Tsinghua Chang Gung Hospital

    lead OTHER

Principal Investigators

  • Jian Z Xiao, Doctor · Beijing Tsinghua Changgeng Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2018-08-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02502344 on ClinicalTrials.gov